Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Shayan Shakeraneh"'
Publikováno v:
Antimicrobial Stewardship & Healthcare Epidemiology, Vol 2 (2022)
Over a 4-year period, the antimicrobial stewardship team reviewed all positive (PCR+/Tox+) and indeterminate (PCR+/Tox−) cases with the most responsible physician for classification of patients as infection or colonization. Among 501 indeterminate
Externí odkaz:
https://doaj.org/article/df1fcf8344c7425f90f3ba0f4605bb96
Autor:
Joseph Ragaz, John J Spinelli, Hong Qian, Hubert Wong, Shayan Shakeraneh, Joel Fox, Kenneth S Wilson
Publikováno v:
Cancer Research. 82:P1-10
BACKGROUND. Large scale clinical hormone replacement therapy [HRT] studies have yielded conflicting breast cancer [BrCa] outcomes. The studies reviewed include:. Two Non-Randomized Studies [Non-RS], based on either estrogen+progestin Provera [E+P HRT
Publikováno v:
Cancer Research. 79:P6-13
OBJECTIVE: To quantitate breast cancer incidence (BrCa-I) and mortality (BrCa-M) outcome differences between the two Women's Health Initiative (WHI) HRT trials,1,2 the ratio of hazards was calculated for estrogen-alone based hormone replacement thera
Publikováno v:
Cancer Research. 79:P6-13
OBJECTIVE: To compare, in the setting of breast cancer (BrCa) prevention, the impact of estrogen-based hormone replacement therapy (E-HRT) vs. tamoxifen (TAM) on breast cancer mortality (BrCa-M) and breast cancer case fatality ratio (BrCa-CFR), by an
Autor:
Hong Qian, Joel Fox, J-Y Yoon, Hubert Wong, Kenneth S. Wilson, Shayan Shakeraneh, Joseph Ragaz, JS Simpson
Publikováno v:
Cancer Research. 76:P1-07
INTRODUCTION: Following the first phase of this project [Ref 1], we correlate here the rates of DCIS with BrCaMOR, in two regions of Canada - British Columbia [BC] and Atlantic Provinces [Atl.P]. We previously reported higher compliance in screening
Publikováno v:
Cancer Research. 72:P4-13
BACKGROUND. Estrogen [E] for women entering menopause is not perceived beneficial for either iBrCa or CHD. However, data from RCTs suggest that use of Estrogen reduces: a. rates of invasive breast cancer [iBrCa], andb. atherogenesis, vessel pathology
Autor:
Joseph Ragaz, Shayan Shakeraneh
Publikováno v:
Management of Breast Diseases ISBN: 9783319463544
Background: The Women’s Health Initiative [WHI] Hormone Replacement Trials [HRT] are the two largest randomized placebo-controlled studies in the history of HRT research. Their randomized nature secures more accuracy than past observational studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3c754548020a2ded6c5e7e727198b9d
https://doi.org/10.1007/978-3-319-46356-8_25
https://doi.org/10.1007/978-3-319-46356-8_25
Autor:
Shayan Shakeraneh, Joseph Ragaz
Publikováno v:
Management of Breast Diseases ISBN: 9783319463544
As seen in the first part of this review, the primary objective of the WHI HRT trials was to evaluate the impact of HRT on cardiac and degenerative conditions among elderly women, where these outcomes are most frequent, and not necessarily to study t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f90a0ddadc5d5ead346343890fe6c71f
https://doi.org/10.1007/978-3-319-46356-8_26
https://doi.org/10.1007/978-3-319-46356-8_26
Publikováno v:
Journal of Clinical Oncology. 34:e13069-e13069
e13069Background: To correlate age-standardized rates [ASRs] of DCIS, BrCaINV and BrCaMOR, separately for ages 50. British Columbia [BC] is known for earlier introduction, tighter adherence to, and more uniformity of ScreenMam than the Atlantic Provi
Autor:
Joseph Ragaz, Shayan Shakeraneh, Joel Fox, Andy Coldman, Kenneth S. Wilson, Hubert Wong, John J. Spinelli
Publikováno v:
Journal of Clinical Oncology. 32:1601-1601
1601 Background: The objective of this study is to compare main Breast Cancer outcomes in two regions of Canada with different access to Provincial Guideline-based cancer care [GCC]. Since the 1960's, British Columbia has had a centralized provincial